A patented and clinically-tested blend of key olive polyphenols (including hydroxytyrosol and tyrosol) from olive fruit extract. Polyphenols from olives and olive oil (hydroxytyrosol and tyrosol) possess antioxidant and anti-inflammatory properties.
tPureVida™ is a patent-pending combination of Trephenol™ olive fruit extract, Curcumin C3 Complex® (Sabinsa Corporation), and a custom blend of marine omega-3 fatty acids.
aIn a prospective, multicenter, pilot study of 45 postmenopausal women (mean age 59 years) with Stage 0-IIIA hormone receptor−positive breast cancer receiving stable doses of adjuvant aromatase inhibitor therapy for 2 to 5 years from their diagnosis, PureVida™ significantly reduced C-reactive protein (CRP) levels (p<0.05). In 45 patients examined for safety, reported adverse events (AEs) included abdominal pain in 1 patient (2.2%), constipation in 5 patients (11.1%), headache in 3 patients (6.7%), and abnormal product taste (fish taste) in 14 patients (31.1%). No patients had to discontinue therapy due to AEs. This study was conducted by OliVentures. There has been substantial separate research into the potential benefits of each of the ingredients in PureVida™. The PureVida™ trial has not been peer reviewed and more research is needed before drawing any final conclusions.
*This product is not intended to diagnose, treat, cure, or prevent any disease. Supportive but not conclusive research shows that consumption of EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease. PureVida™ may lower elevated CRP levels. CRP is one of several markers of inflammation in the body. PureVida™ may reduce joint pain in women taking aromatase inhibitors. These statements have not been evaluated by the U.S. Food and Drug Administration (FDA).